By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
"Botox and fillers are not even FDA-approved for most of the places we use them," she noted. "Some individuals might ...
Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...
Even though some GLP-1 medications like Wegovy and Zepbound are FDA-approved for weight loss, getting insurance ...